Part 4/7:
A key theme across the administration's healthcare strategy is reducing the lengthy timelines traditionally associated with drug development. Currently, it takes approximately 10 to 12 years for a new drug to reach the market, a process deemed inefficient and outdated. To address this, the administration is challenging those standards by implementing a new program designed to produce decisions on drug approval within weeks, thereby expediting access to potentially life-saving treatments.